N-Desmethyl Pimavanserin is the demethylated metabolite of Pimavanserin, which is an agonist of the 5-HT2A receptor approved in 2016 as an atypical antipsychotic for the treatment of Parkinson's disease psychosis.

纯度：≥98%

CAS：639863-77-7